Health · 3 views
Is It Over for DAPT After Left Atrial Appendage Closure?
(MedPage Today) -- Antithrombotic monotherapy was similar to dual antiplatelet therapy (DAPT) for 6-month outcomes after left atrial appendage (LAA) closure, the SIMPLAAFY trial showed.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 3 Community interest
Brief read Under 1 min brief 22 words
AI Summary
Antithrombotic monotherapy produced outcomes comparable to dual antiplatelet therapy for six months following left atrial appendage closure, according to the SIMPLAAFY trial.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- From DNA marks to RNA control: A new clue to acute myeloid leukemiaContinue reading
- Tiny structures in our spines could hold clues to why our backs wear outContinue reading
- A Pediatrician, a Pastor, and a Paralympian Just Did Wonders for Kids’ Mental HealthContinue reading
- Chronic illness linked to higher prescription drug misuseContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow